WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced June 27 that Dr. Anindya Sen and Patricia Posey Sen will pay $1.208 million to resolve state and federal False Claims Act allegations.
“The Department of Justice is committed to maintaining the integrity of the health care system and ensuring that patient safety, not physician misconduct, determines health care decisions,” said acting assistant attorney general Chad A. Readler of the Justice Department’s Civil Division.
According to the department, the medical practice managed by the Sens billed Medicare and Tennessee Medicaid (TennCare) for anticancer and infusion drugs that were not approved by the U.S. Food and Drug Administration for use within the United States.
“Medical providers and practitioners that distribute and disseminate unapproved and potentially unsafe drugs—especially those used in cancer treatment—put at risk the health and safety of the American consumer,” said U.S. attorney Nancy Stallard Harr for the Eastern District of Tennessee. “This settlement reflects our ongoing commitment to safeguard the federal health care programs and vital care that they provide.”
Handling the case for the United States were the Civil Division’s Commercial Litigation Branch, the U.S. Attorney’s Office for the Eastern District of Tennessee, the Department of Health and Human Services Office of General Counsel, the Food and Drug Administration Office of Criminal Investigations and Office of Chief Counsel, the FBI’s Knoxville Division and the Tennessee Bureau of Investigation.